~~<i id='AC695B4583'><strike id='AC695B4583'><tt id='AC695B4583'><pre id='AC695B4583'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：entertainment 2025-09-30 02:28:40 Page View：8275

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts

leisure time

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Europe sees delivery challenges ahead on Alzheimer's therapies

VialsandpackagingforLeqembi,anewAlzheimer'smedicationapprovedintheU.S.,butnotyetinEurope.Illustratio

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

1:30Twosixty-five-footraceyachtshadacloseencounterwithorcawhalesastheyapproachedtheStraitofGibraltar